142 related articles for article (PubMed ID: 8609055)
1. Evaluation of the relative cytotoxic effects of anticancer agents in serum-supplemented versus serum-free media using a tetrazolium colorimetric assay.
Tsai CM; Perng RP; Chang KT; Venzon D; Gazdar AF
Jpn J Cancer Res; 1996 Jan; 87(1):91-7. PubMed ID: 8609055
[TBL] [Abstract][Full Text] [Related]
2. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Horiuchi N; Nakagawa K; Sasaki Y; Minato K; Fujiwara Y; Nezu K; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
Carmichael J; Mitchell JB; DeGraff WG; Gamson J; Gazdar AF; Johnson BE; Glatstein E; Minna JD
Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
[TBL] [Abstract][Full Text] [Related]
4. [Cell culture and its application--in vitro evaluation of anticancer activity using human tumor cell lines].
Tashiro T
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2107-12. PubMed ID: 1329672
[TBL] [Abstract][Full Text] [Related]
5. The hollow fiber assay.
Hall LA; Krauthauser CM; Wexler RS; Slee AM; Kerr JS
Methods Mol Med; 2003; 74():545-66. PubMed ID: 12415720
[No Abstract] [Full Text] [Related]
6. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
Jordan JP; Hand CM; Markowitz RS; Black P
J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
Fricker SP; Buckley RG
Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
Ford CH; Richardson VJ; Tsaltas G
Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
11. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
12. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Sobottka SB; Berger MR
Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitivity testing of small cell lung cancer using the MTT assay.
Campling BG; Pym J; Baker HM; Cole SP; Lam YM
Br J Cancer; 1991 Jan; 63(1):75-83. PubMed ID: 1846554
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
Jensen PB; Roed H; Sehested M; Demant EJ; Vindeløv L; Christensen IJ; Hansen HH
Cancer Chemother Pharmacol; 1992; 31(1):46-52. PubMed ID: 1360876
[TBL] [Abstract][Full Text] [Related]
15. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.
Etievant C; Kruczynski A; Pauwels O; Kiss R
Anticancer Res; 1991; 11(1):305-11. PubMed ID: 2018364
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.
Eliason JF; Kaufmann F; Tanaka T; Tsukaguchi T
Br J Cancer; 1993 Jun; 67(6):1293-8. PubMed ID: 8390284
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
18. Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.
Ganot N; Meker S; Reytman L; Tzubery A; Tshuva EY
J Vis Exp; 2013 Nov; (81):e50767. PubMed ID: 24300943
[TBL] [Abstract][Full Text] [Related]
19. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
[TBL] [Abstract][Full Text] [Related]
20. [Chemosensitivity testing on human bladder cancer cell lines, using MTT-assay].
Sawamura M; Odajima K; Nagakura K; Nakamura H
Nihon Hinyokika Gakkai Zasshi; 1989 Aug; 80(8):1195-202. PubMed ID: 2585919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
